Reuters logo
BRIEF-FDA approves Boehringer Ingelheim's Jardiance for type 2 diabetes
August 1, 2014 / 3:37 PM / 3 years ago

BRIEF-FDA approves Boehringer Ingelheim's Jardiance for type 2 diabetes

Aug 1 (Reuters) - The U.S. Food and Drug Administrarion: * FDA approves Boehringer Ingelheim Pharmaceuticals’ Jardiance to treat type 2

diabetes * FDA says it needs four postmarketing studies for jardiance from Boehringer

ingelheim * For FDA's press release, click (1.usa.gov/1xKLnyF) * Further company coverage

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below